21/08/2026
🎉 "Ten years ago, RDDS started as an experiment in bringing advocates and industry into the same room. Today, it's a proven launchpad for patient-led and patient-partnered research, said Charlene
Son Rigby, CEO of Global Genes. Rare disease progress depends on advocates who know how to navigate research, build the right partnerships, and drive development forward. Ten years in, that's the
commitment RDDS continues to deliver on."
Join RDDS' Fireside Chat with Charlene Son Rigby and Dr. Tim Yu, Boston's Children Hospital on Sept. 10th 2026:
https://buff.ly/ymUoJkK
www.globalgenes.org